Casar said the U.S. government can't sit by idly and do nothing. It needs to do something to address the enormous impact of ...

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Altitude Lab, the platform-first biotech-startup accelerator founded by Recursion (NASDAQ: RXRX), announced today that its portfolio companies have collectively raised more than $205 million in ...

Recursion Pharmaceuticals reported Q1 2026 progress on its AI-driven drug discovery programs, highlighting its first clinical proof of concept and multiple upcoming trial readouts. The company has ...

In this episode of our local program Making Democracy Work, host Lynn Schirk speaks with Dr. Kevin Evans, professor of ...

A literary experiment in AI sycophancy, chatbot therapy and a commentary on modern male loneliness. Two books. One ...

Altitude Lab, the platform-first biotech-startup accelerator founded by Recursion (NASDAQ: RXRX), announced today that its portfolio companies have collectively raised more ...

Hexo Labs has developed the world’s first agent that learns from itself instead of human actions, rapidly increasing the ...

I sometimes get the feeling that the "AI in planning" conversation makes people feel like they are already five steps behind.

A Generalized Recursive Regular Expression Synthesis Framework" by Professor Sangki Ko's research team from the Depa ...